@enrichtrades This is a bad decision for the current subscribers. I have noticed the quality of alerts going down lately and this distraction will just amplify it.
@KevinWill001@trademaster_p@Team2Trading Congrats again Kevin! How do you handle strike prices moving away while entering the bot? Do you skip the trade if it runs too far? Also, do you scale in on EMA touches like Cassie does, or enter full size upfront and let the bot manage TP/SL from there?
@KevinWill001@Team2Trading Congrats Kevin! I am also Team2, and wondering if you could share how you set up the bot and execute trades? Maybe a video would help. Thanks and enjoy the win ๐ฅณ
@TheProfInvestor But the SPCX IPO raise is only around $75B, so Iโm not sure theyโd need to wipe out hundreds of billions from other stocks just to make room.
@vulturetrades Great calls so far. Any chance youโd start a free Discord? X notifications are messy, and Discord would be much easier to follow. Thanks for all you do.
@cremieuxrecueil Yeah, that sounds like $ABCL to me. Less about AI finds miracle drugs from scratch and more about using AI to optimize antibodies / improve targeting / reduce side effects.
@cyberprince_rwo Agreed. If they prove repeatability across programs, I think the rerating could happen very fast. Data + infrastructure becomes the moat, not just a single drug outcome.
@trademaster_p Can you share the download link? I tried signing up on the site, but the welcome email didn't have the download link or subscription details. Thanks.
@JackPrescottX Nothing short of a masterpiece. This will go down in X's history as the most well researched free article ever. Well done Jack. Much appreciated.
@WebullGlobal Hey @WebullGlobal take a note from @RobinhoodApp on how it's done. No oneโs tuning in for your corporate sermons. Get your CEO to actually connect with people the way Vlad does.